Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The biological role of most proteases in vivo is largely unknown. Therefore, to develop robust techniques to analyze the protease degradome in cells and tissues and to elucidate their substrate degradomes we have developed a dedicated and complete human protease and inhibitor microarray that we have called the CLIP-CHIP Oligonucleotides (70-mers) for identifying all 715 human proteases, inactive homologs and inhibitors were spotted in triplicate onto glass slides with a dedicated subarray containing oligonucleotides for specific human breast carcinoma genes. Initial analyses revealed the elevated expression of a number of proteases in invasive ductal cell carcinoma including ADAMTS17, carboxypeptidases A5 and M, tryptase-gamma and matriptase-2. Matrix metalloproteinases (MMPs) showed a restricted expression pattern in both normal and cancerous breast tissues with most expressed at low levels. However, of the several MMPs expressed in significant quantities, the carcinoma samples showed only slightly elevated amounts other than for MMP-28 which was strongly elevated. To discover new protease substrates we developed a novel yeast two-hybrid approach we term 'inactive catalytic domain capture' (ICDC). Here, an inactive mutant protease catalytic domain lacking the propeptide was used as a yeast two hybrid bait to screen a human fibroblast cDNA library for interactor proteins as a substrate trap. Wnt-induced signaling protein-2 (WISP-2) was identified by ICDC and was biochemically confirmed as a new MMP substrate. In another approach we used isotope-coded affinity tag (ICAT) labeling with tandem mass spectrometry to quantitate the levels of secreted or shed extracellular proteins in MDA-MB-231 breast carcinoma cell cultures in the presence or absence of membrane type 1-MMP (MT1-MMP) overexpression. By this proteomic approach we identified and biochemically confirmed that IL-8, the serine protease inhibitor SLPI, the death receptor-6, pro-TNF-alpha and CTGF are novel substrates of MT1-MMP. The utility and quantitative nature of ICAT with MS/MS analysis as a new screen for protease substrate discovery based on detection of cleaved or shed substrate products should be readily adaptable to other classes of protease for assessing proteolytic function in a cellular context.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108 · cited 4×
“development (Holmbeck et al., 1999) and in disease (Yamanaka et al., 2000; Egeblad and Werb, 2002; Seiki, 2003).”
BackgroundInfluentialQuantitative analysis of complex protein mixtures using isotope-coded affinity tags
Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., & Aebersold, R. (1999) · Nature Biotechnology · doi:10.1038/13690 · Cited by 4,683 · cited 2×
“By labeling proteins with stable isotope reagents, most notably isotope coded affinity tags, ICAT (Gygi et al., 1999), protein identification and comparative quantitation of protein levels by MS/MS can be made between experimental and control samples (see Figure 1).”
BackgroundA metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149 · cited 1×
“ADAM-17 is the enzyme thought to be primarily responsible for the generation of mature TNF-a from a membrane bound precursor (Black et al., 1997; Moss et al., 1997).”
BackgroundHolmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Gehron Robey, P., Poole, A. R., Pidoux, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80064-1 · Cited by 1,298
Ohuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M., & Okada, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2446 · Cited by 938 · cited 3×
“, 2001) and cleaves native type I collagen, fibronectin and other matrix proteins in vitro (Ohuchi et al., 1997; Tam et al., 2002) and so is important for normal growth and”
Background
Cited by
Extracellular matrix structure
Theocharis, A. D., Skandalis, S. S., Gialeli, C., & Karamanos, N. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.001 · Cited by 2,598
“generating new bioactive molecules [267-271].”
Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1821 · Cited by 1,214
Self-citationSpinale, F. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2007 · Cited by 1,120
Emerging roles of proteases in tumour suppression
López-Otín, C., & Matrisian, L. M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2228 · Cited by 802
Self-citationVandooren, J., Van den Steen, P. E., & Opdenakker, G. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.770819 · Cited by 766
Matrix Metalloproteinases as Modulators of Inflammation
MANICONE, A., & MCGUIRE, J. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2007.07.003 · Cited by 617
Metalloproteinases: Mediators of Pathology and Regeneration in the CNS
Yong, V. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1807 · Cited by 582
Cauwe, B., Van den Steen, P. E., & Opdenakker, G. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701340019 · Cited by 381
The role of matrix metalloproteinases in aging: Tissue remodeling and beyond
Freitas-Rodríguez, S., Folgueras, A. R., & López-Otín, C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.05.007 · Cited by 354
Self-citationIn search of partners: linking extracellular proteases to substrates
Overall, C. M., & Blobel, C. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2120 · Cited by 349
Self-citationTowards third generation matrix metalloproteinase inhibitors for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603043 · Cited by 340
Self-citationZymography methods for visualizing hydrolytic enzymes
Vandooren, J., Geurts, N., Martens, E., Van den Steen, P. E., & Opdenakker, G. (2013) · Nature Methods · doi:10.1038/nmeth.2371 · Cited by 320
Cauwe, B., & Opdenakker, G. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.501783 · Cited by 299
Lewis, J. D., Lee, A. H.-Y., Hassan, J. A., Wan, J., Hurley, B., Jhingree, J. R., Wang, P. W., Lo, T., Youn, J.-Y., Guttman, D. S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315520110 · Cited by 210
“Catalytically inactive enzymes have been found to exhibit stabilized interactions with substrates (19, 20).”
BackgroundStructural basis and specificity of human otubain 1-mediated deubiquitination
Edelmann, M. J., Iphöfer, A., Akutsu, M., Altun, M., di Gleria, K., Kramer, H. B., Fiebiger, E., Dhe-Paganon, S., & Kessler, B. M. (2009) · Biochemical Journal · doi:10.1042/bj20081318 · Cited by 209
Predicting in vivo binding sites of RNA-binding proteins using mRNA secondary structure
Li, X., Quon, G., Lipshitz, H. D., & Morris, Q. (2010) · RNA · doi:10.1261/rna.2017210 · Cited by 176
Rivera, S., García-González, L., Khrestchatisky, M., & Baranger, K. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03178-2 · Cited by 111
García-González, L., Pilat, D., Baranger, K., & Rivera, S. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00244 · Cited by 88
Metadata
- Authors
- Overall, C. M., Tam, E. M., Kappelhoff, R., Connor, A., Ewart, T., Morrison, C. J., Puente, X., López-Otín, C., & Seth, A.
- Venue
- Biological Chemistry
- Publisher
- Walter de Gruyter GmbH
- Published
- 2004-01-07
- Volume
- 385
- Issue
- 6
- Pages
- 493-504
- ISSN
- 1431-6730 (ISSN-L)
- OpenAlex
- W2046582315
- Cited by
- 127
- References
- 5
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.